News

Select Sector

Thank you! Your submission has been received!
Oops! Something went wrong while submitting the form.
VC

The Hindu Business Line

Jul 22, 2025

It’s time for a reality check for AI startups

As they begin to tap the unfolding opportunities in AI, startups in this space are in for a reality check. Some of the early entrants to this space post LLM (large language model) era seem to be facing challenges, which range from working capital needs to finding customers.

It’s time for a reality check for AI startups
Enterprise

StartupNews.fyi

Jul 7, 2025

Monetize360 Raises Investment from Abyro Capital to Redefine Enterprise Monetization Infrastructure

Monetize360, a fast-growing SaaS company modernizing enterprise revenue infrastructure, today announced a strategic investment from Abyro Capital, a US-India venture capital firm focused on globally ambitious, deep-tech ventures. The investment marks a key milestone in Monetize360’s mission to power intelligent, scalable monetization for the AI-native enterprise.

Monetize360 Raises Investment from Abyro Capital to Redefine Enterprise Monetization Infrastructure
Semiconductors

Economic Times

Jul 3, 2025

Deeptech startup Maieutic Semiconductor raises $4.15 million from Endiya Partners, Exfinity Venture Partners

Bengaluru-based deeptech startup Maieutic Semiconductor has raised $4.15 million in seed funding in a round co-led by Endiya Partners and Exfinity Venture Partners.

Deeptech startup Maieutic Semiconductor raises $4.15 million from Endiya Partners, Exfinity Venture Partners
Lifesciences

OphthalmologyTimes

Jun 18, 2025

Eyestem completes phase 1 study of Eyecyte-RPE in patients with geographic atrophy

Eyestem has announced the completion of its phase 1 study for its investigational retinal pigment epithelium (RPE) cell therapy, Eyecyte-RPE. The company has submitted the results to the Central Drugs Standard Control Organisation (CDSCO), India's national regulatory body for cosmetics, pharmaceuticals, and medical devices, for permission to start phase 2 of the study.

Eyestem completes phase 1 study of Eyecyte-RPE in patients with geographic atrophy
No items found.